Azienda Policlinico Vittorio Emanuele

Catania 95123

0 studies enrolling now · 5 studies all time

What they study most

Chronic Graft Versus Host Disease, Chronic Graft-versus-host Disease, Lymphoma, Myelofibrosis, NonSegmental Vitiligo, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia Vera Myelofibrosis, Postlung Transplant (Bronchiolitis Obliterans), Primary Myelofibrosis

Studies at this site

• A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib — Stopped early
• A Study to Evaluate Efficacy and Safety of Povorcitinib in Participants With Nonsegmental Vitiligo (STOP-V2) — Running, not enrolling
• To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313) — Stopped early
• GRAVITAS-309: Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease — Stopped early
• A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor — Completed